Supriya Lifescience Ltd. IPO

One of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, the company has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.

RHP
View
DRHP
View
Open Date

2021-12-16

Close Date

2021-12-20

Supriya Lifescience Ltd. IPO Details

Check out the issue details for Supriya Lifescience Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 274

Price Band

₹ 265 - 274

Issue Size

700 Cr.

Issue Type

Book Built

Open

2021-12-16

Close

2021-12-20

Listingprice

₹ 421

ListingGain

53.65%

Listing Date

2021-12-28

CMP

₹ 703.45

Current Return

156.73%

Supriya Lifescience Ltd. News

Supriya Lifescience submits analyst meet intimation 7 Nov, 4:40PM Supriya Lifescience - Quaterly Results28 Oct, 1:49PM Supriya Lifescience - Quaterly Results28 Oct, 1:49PM Supriya Lifescience - Quaterly Results28 Oct, 1:49PM Supriya Lifescience informs about board meeting21 Oct, 12:44PM Supriya Lifescience informs about compliance certificate9 Oct, 1:25PM Supriya Lifescience informs about outcome of AGM30 Sep, 5:00PM Supriya Lifescience informs about analyst meet11 Sep, 12:16PM Supriya Lifescience informs about analyst meet9 Sep, 5:18PM Supriya Lifescience informs about transcript of earnings call19 Aug, 12:57PM Supriya Lifescience’s net profit rises 57% in Q110 Aug, 3:12PM Supriya Lifescience - Quaterly Results10 Aug, 2:18PM Supriya Lifescience - Quaterly Results10 Aug, 2:18PM Supriya Lifescience - Quaterly Results10 Aug, 2:18PM Supriya Lifescience informs about earnings call5 Aug, 11:50AM Supriya Lifescience submits analyst meet intimation 7 Jun, 4:45PM Supriya Lifescience - Quaterly Results28 May, 6:31PM Supriya Lifescience - Quaterly Results28 May, 6:31PM Supriya Lifescience informs about annual secretarial compliance report27 May, 3:04PM Supriya Lifescience informs about disclosure24 Apr, 2:50PM

Company Financials

You can get the following financial statements of Supriya Lifescience Ltd. as of now.

Exchange

NSE: SUPRIYA BSE: 543434

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Supriya LifeSciences IPO is as:

  • The issue size of the IPO is 700 Cr.
  • The price band ranges from Rs 265 to Rs 274.
  • The shares of Supriya LifeSciences ltd will list on 28th December 2021.
  • The latest tentative GMP of Supriya LifeSciences IPO is Rs 150.
  • The shares of Supriya LifeSciences is subscribed 71.51 Times as of 20th December 2021.

 

Supriya LifeSciences IPO Valuation

The approx valuation of Supriya LifeSciences IPO based on its price band and DRHP/RHP is:

Particulars Value
Upper Price Band Rs 274
Existing Shares (Qty) 7.31 Cr
Fresh Issue 200  Cr
Market Cap 2202.94 Cr
EPS (FY21) Rs 16.92
PE Ratio 16.19x
Industry PE 23.02x

 

Supriya LifeSciences IPO Issue Size

Supriya LifeSciences IPO issue size is 700 Cr.

Issue Amount
Fresh Issue 200 Cr
Offer For Sale 500 Cr

 

Supriya LifeSciences IPO Market Lot

An Individual can apply for a minimum 1 lot of 54 shares and a maximum of 13 lots of 702 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 54 Rs 14,796
 Maximum 13 702 Rs 1,92,348

 

Supriya LifeSciences IPO Share Offer

The shares of Supriya LifeSciences is subscribed 71.51 Times as of 20th December 2021. The category-wise share subscription is as follows:

Category % Offered Subscription
Qualified Institutional Minimum 75% 31.83 Times
Non-Institutional Maximum 15% 161.22 Times
Retail Individual Maximum 10% 56.01 Times
Total   71.51 Times

 

Supriya LifeSciences IPO Grey Market Premium

As on GMP (Tentative)
17 December 2021 Rs 280
18 December 2021 Rs 280
19 December 2021 Rs 180
20 December 2021 Rs 180
21 December 2021 Rs 150

It is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Find below the dates for Supriya LifeSciences IPO:

Schedule Date
Basis of Allotment 23 December 2021
Refunds 24 December 2021
Credit to Demat Account 27 December 2021
IPO Listing Date 28 December 2021

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 311.64 391.22 530.05 460.94 570.37
Total Expenditure 213.26 218.07 316.06 332.5 394.68
Operating Profit 98.38 173.15 213.98 128.44 175.69
Other Income 11.07 5.01 7.58 9.94 10.96
Interest 6.85 4.08 4.2 3.08 5.15
Depreciation 6.38 6.76 10.12 11.82 15.81
Exceptional Items 0 0 0 0 0
Profit Before Tax 96.23 167.31 207.25 123.49 165.69
Provision for Tax 22.82 43.72 55.44 33.63 46.58
Net Profit 73.4 123.59 151.81 89.86 119.11
Adjusted EPS (Rs.) 1 1.69 1.89 1.12 1.48

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 14.64 14.64 16.1 16.1 16.1
Total Reserves 134.56 253.95 599.59 683.36 799.27
Borrowings 2.39 0 0 0 0
Other N/C liabilities 29.46 30.86 19.38 25.04 28.98
Current liabilities 155.39 146.02 99.7 95.78 79.57
Total Liabilities 336.43 445.47 734.76 820.28 923.92
Assets
Net Block 97.99 100.04 189.77 261.54 310.13
Capital WIP 40.21 78.79 43.41 67.63 148.83
Intangible WIP 0 0 0 0 0
Investments 0.05 0.05 0.05 25.3 63.8
Loans & Advances 0.18 1.13 3.98 0.93 0.68
Other N/C Assets 0 0 0 0 0
Current Assets 197.99 265.46 497.54 464.89 400.48
Total Assets 336.43 445.47 734.76 820.28 923.92
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Other Income 2.47 3.07 2.19 2.22 2.52
Profit Before Tax 29.78 40.1 53.17 59.78 62.06
Tax 5.89 10.31 16.24 15.13 15.92
Profit After Tax 23.88 29.79 36.93 44.64 46.15
Adjusted EPS (Rs) 2.97 3.7 4.59 5.55 5.73

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 68.3 0
Jun 2024 68.3 0
Mar 2024 68.3 0
Dec 2023 68.3 0
Sep 2023 68.3 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 96.23 167.31 207.25 123.49 165.69
Adjustment 10.24 5.39 6.87 4.61 2.4
Changes in Assets & Liabilities 36.6 -66.82 -104.35 -33.82 -17.14
Tax Paid -27.01 -29.99 -60.96 -30.68 -37.65
Operating Cash Flow 116.06 75.89 48.8 63.61 113.31
Investing Cash Flow -24.53 -46.8 -59.82 -123.65 -173.58
Financing Cash Flow -29.23 -14.52 149.65 -10.28 -22.36
Net Cash Flow 62.31 14.57 138.63 -70.32 -82.63
X